CX3CL1 ICD may hold significant translational potential for neuroprotection in Alzheimer’s disease and for disorders associated with insulin resistance (Gayen et al., 2022). This evidence concerns the gene CX3CL1 and early-onset autosomal dominant Alzheimer disease.